Search Results 7601-7610 of 40896 for oral
Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas. Obstet Gynecol. 2023 May 01; 141(5):901-910. Epub 2023 Apr 05. View ...
May be on oral therapy (including metformin) or insulin. Most recent HgbA1c level measuring between 6.5 -10 within the last 3 months. May be on stable (> 4 ...
... oral steroids. "Steroids have been used for 75 years, but there was minimal evidence about dosing," says Dr. Duarte García. "This research provides ...
* Participant has demonstrated intolerance or inadequate response to one or more of the following categories of drugs: aminosalicylates, oral locally acting ...
Location Rochester, Minnesota Clinical Profile SUMMARY Dr. Torgerson's areas of clinical and research interest include: Oral and genital mucosal disorders ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery ... Oral and thr...oat cancer, Head and neck cancer, Mouth cancer, Thyroid ...
We're probably one of the most aggressive centers in looking at dose de-escalation in terms of radiation for patients with HPV-related oral pharynx cancers.
Use of these agents is prohibited during the study. - Treatment with oral or sublingual immunotherapy within 6 months of OLE Day 1. Use of these agents is ...
Administration of oral immunosuppressants when the dose has NOT been stable during the preceding 2 months (2 weeks for long-term corticosteroid therapy) and ...
Acceptable methods include surgical sterilization, hormonal contraceptives (such as oral contraceptives, Depo-Provera, NuvaRing), condoms used with a spermicide ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!